Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

ClinicalTrials.gov ID: NCT00663260

Public ClinicalTrials.gov record NCT00663260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 12:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2/3 Trial to Evaluate the Glycemic Efficacy, Renal Safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether dapagliflozin is effective in the treatment of type 2 diabetes in subjects with poor blood sugar control and moderate renal impairment

Study identification

NCT ID
NCT00663260
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
631 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
Nov 30, 2009
Completion
May 31, 2011
Last update posted
Feb 9, 2017

2008 – 2011

United States locations

U.S. sites
34
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Vista Medical Research, Inc. Mesa Arizona 85206
Valley Research Fresno California 93720
Marin Endocrine Care & Research, Inc. Greenbrae California 94904
Office Of Richard Cherlin, Md Los Gatos California 95032
Diabetes Medical Center Of California Northridge California 91325
Apex Research Of Riverside Riverside California 92505
La Biomed At Harbor Ucla Med Ctr. Torrance California 90502
Endocrine Associates Of The Rockies Denver Colorado 80220
Panhandle Family Care Associates Marianna Florida 32446
Genesis Clinical Research Tampa Florida 33614
Endocrine Research Solutions, Inc. Roswell Georgia 30076
Twin Cities Clinical Research Brooklyn Center Minnesota 55430
Kcva Medical Center Research Svc (151) Kansas City Missouri 64128
Va Nebraska-Western Iowa Health Care System (Nwihcs) Omaha Nebraska 68105
University Of Medicine And Dentistry Of New Jersey Voorhees Township New Jersey 08043
Winthrop University Hospital Mineola New York 11501
Slocum-Dickson Medical Group, Pllc New Hartford New York 13413
Community Health Care Of Manchester Akron Ohio 44319
Center For Thyroid Diseases And Endocrinology Beachwood Ohio 44122
Physician Research, Inc. Zanesville Ohio 43701
Univ Of Oklahoma Health Science Center Oklahoma City Oklahoma 73104
Rogue Valley Clinical Research Medford Oregon 97504
Drexel University College Of Medicine Philadelphia Pennsylvania 19102
Thomas Jefferson University Philadelphia Pennsylvania 19107
Low Country Internal Medicine Of Sc, Pa Charleston South Carolina 29406
Carolina Health Specialists Myrtle Beach South Carolina 29572
Palmetto Clinical Research Summerville South Carolina 29485
Research Institute Of Dallas Dallas Texas 75231
Westbury Medical Clinic P.A. Houston Texas 77005
The Strelitz Diabetes Center Norfolk Virginia 23510
Capital Clinical Research Center Olympia Washington 98502
Cedar Research Llc Tacoma Washington 98405
Aurora Advanced Healthcare Milwaukee Wisconsin 53209
Zablocki Veterans Affairs Medical Center Milwaukee Wisconsin 53295

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00663260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2017 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00663260 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →